Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)

SHA:600521 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	9,495	8,249	8,183	6,603	6,456
Other Revenue	52.87	59.54	82.56	40.95	29.5
Revenue	9,547	8,309	8,266	6,644	6,485
Revenue Growth (YoY)	14.91%	0.52%	24.42%	2.44%	20.36%
Cost of Revenue	3,738	3,376	3,180	2,671	2,385
Gross Profit	5,809	4,933	5,086	3,973	4,100
Selling, General & Admin	3,143	2,592	2,534	2,448	2,080
Research & Development	986.69	982.99	925.53	942.26	565.7
Other Operating Expenses	18.41	5.69	3.63	65.21	50.13
Operating Expenses	4,185	3,572	3,508	3,470	2,725
Operating Income	1,625	1,360	1,578	502.48	1,375
Interest Expense	-219.8	-231.69	-220.02	-166.34	-135.33
Interest & Investment Income	53.22	39.48	25.83	180.61	19.57
Currency Exchange Gain (Loss)	76.9	60.1	208.94	-50.99	-145.37
Other Non Operating Income (Expenses)	-5.8	-5.14	-3.91	-4.32	-3.86
EBT Excluding Unusual Items	1,529	1,223	1,589	461.44	1,110
Impairment of Goodwill	-	-6.46	-	-	-
Gain (Loss) on Sale of Investments	-98.21	-162.9	-70	299.81	26.09
Gain (Loss) on Sale of Assets	2.33	-0.29	-16.1	-9.59	19.15
Asset Writedown	-30.13	-32.95	-2	-0.16	-13.58
Other Unusual Items	60.55	79.92	8.23	35.42	73.68
Pretax Income	1,464	1,100	1,509	786.93	1,215
Income Tax Expense	356.15	283.07	332.89	306.28	220.76
Earnings From Continuing Operations	1,107	817.25	1,176	480.64	994.6
Minority Interest in Earnings	11.52	13.22	-8.25	6.89	-64.78
Net Income	1,119	830.47	1,168	487.54	929.82
Net Income to Common	1,119	830.47	1,168	487.54	929.82
Net Income Growth	34.74%	-28.88%	139.52%	-47.57%	63.24%
Shares Outstanding (Basic)	1,449	1,457	1,442	1,434	1,453
Shares Outstanding (Diluted)	1,449	1,457	1,460	1,434	1,453
Shares Change (YoY)	-0.52%	-0.19%	1.80%	-1.30%	4.58%
EPS (Basic)	0.77	0.57	0.81	0.34	0.64
EPS (Diluted)	0.77	0.57	0.80	0.34	0.64
EPS Growth	35.09%	-28.75%	135.29%	-46.88%	56.10%
Free Cash Flow	319.33	624.63	-1,074	-1,496	278.97
Free Cash Flow Per Share	0.22	0.43	-0.73	-1.04	0.19
Dividend Per Share	0.250	0.200	0.240	0.100	0.200
Dividend Growth	25.00%	-16.67%	140.00%	-50.00%	10.01%
Gross Margin	60.85%	59.37%	61.53%	59.80%	63.23%
Operating Margin	17.02%	16.37%	19.09%	7.56%	21.20%
Profit Margin	11.72%	9.99%	14.13%	7.34%	14.34%
Free Cash Flow Margin	3.35%	7.52%	-12.99%	-22.52%	4.30%
EBITDA	2,510	2,141	2,230	1,050	1,846
EBITDA Margin	26.29%	25.76%	26.98%	15.81%	28.46%
D&A For EBITDA	885.71	780.37	652.55	547.8	470.83
EBIT	1,625	1,360	1,578	502.48	1,375
EBIT Margin	17.02%	16.37%	19.09%	7.56%	21.20%
Effective Tax Rate	24.33%	25.73%	22.06%	38.92%	18.16%
Revenue as Reported	9,547	8,309	8,266	6,644	6,485
Advertising Expenses	1,417	1,036	1,034	999.39	783.51

Source: S&P Global Market Intelligence. Standard template. Financial Sources.